Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PRLD — Prelude Therapeutics Inc

CIK 1214717 BOSTON, MA
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,487,124
+$3,452,718 QoQ
Shares Held
841,862
+178.3% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 75 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. PRLD ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PRLD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,487,124 841,862
2026-03-31 $1,034,406 302,458
2025-12-31 $791,369 272,886
2025-09-30 $313,297 217,568
2025-06-30 $176,011 217,568
2025-03-31 $311,004 404,955
2024-12-31 $512,977 402,336
2024-09-30 $810,851 391,716
2024-06-30 $1,379,033 361,951
2024-03-31 $1,714,135 361,632
2023-12-31 $1,491,797 349,367
2023-09-30 $1,023,099 331,100
2023-06-30 $1,090,323 242,294
2023-03-31 $831,652 145,904
2022-12-31 $873,849 144,677
2022-09-30 $1,011,931 153,091
2022-06-30 $708,046 135,641
2022-03-31 $1,432,274 207,576
2021-12-31 $2,647,318 212,636
2021-09-30 $7,786,625 249,172
2021-06-30 $6,391,704 223,252
2021-03-31 $8,630,946 199,191
2020-12-31 $13,710,983 191,628